Page last updated: 2024-11-07

lynestrenol and Hormone-Dependent Neoplasms

lynestrenol has been researched along with Hormone-Dependent Neoplasms in 1 studies

Lynestrenol: A synthetic progestational hormone used often in mixtures with estrogens as an oral contraceptive (CONTRACEPTIVES, ORAL).

Research Excerpts

ExcerptRelevanceReference
"Intratumoral activity of the enzyme 17 beta-hydroxysteroid dehydrogenase (17 beta-HSD) was measured in 55 patients with breast cancer (17 pre- and 38 post-menopausal) before and/or after 8 days of a progestin treatment (lynestrenol 10 mg/day)."3.67[Evaluation of 17-beta-hydroxysteroid dehydrogenase activity as a marker of the hormone dependence of breast cancers]. ( Allali, F; Debertrand, P; Diebold, N; Durand, JC; Fournier, S; Kuttenn, F; Martin, PM; Mauvais-Jarvis, P; Sterkers, N, 1985)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fournier, S1
Allali, F1
Durand, JC1
Sterkers, N1
Debertrand, P1
Diebold, N1
Martin, PM1
Kuttenn, F1
Mauvais-Jarvis, P1

Other Studies

1 other study available for lynestrenol and Hormone-Dependent Neoplasms

ArticleYear
[Evaluation of 17-beta-hydroxysteroid dehydrogenase activity as a marker of the hormone dependence of breast cancers].
    Pathologie-biologie, 1985, Volume: 33, Issue:6

    Topics: 17-Hydroxysteroid Dehydrogenases; Adult; Aged; Breast; Breast Neoplasms; Estradiol; Evaluation Studi

1985